{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T03:02:36Z","timestamp":1769655756242,"version":"3.49.0"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T00:00:00Z","timestamp":1682380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cancer recurrence remains a significant problem, and most postoperative recurrences of non-small cell lung cancer (NSCLC) develop within 5 years after resection. We present a rare case of ultra-late recurrence of NSCLC accompanying choroidal metastasis with <jats:italic>KIF13A-RET<\/jats:italic> fusion 14 years after the definitive surgery.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>A 48-year-old female patient who had never-smoked presented with decreased visual acuity. She had been treated with right upper lobe lobectomy followed by adjuvant chemotherapy 14 years prior. Fundus photographs revealed bilateral choroidal metastatic lesions. Positron emission tomography-computed tomography (PET-CT) scans showed extensive bone metastases and focal hypermetabolism in the left uterine cervix. An excision biopsy of the uterus showed primary lung adenocarcinoma with immunohistochemistry of TTF-1+. Plasma next-generation sequencing (NGS) identified the presence of <jats:italic>KIF13A-RET<\/jats:italic> fusion. After 6 months of selpercatinib therapy, PET-CT revealed a partial response for bone and uterine metastasis and stable disease for choroidal lesions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this case report, we are reporting a rare case of ultra-late recurrence of NSCLC in a patient with choroidal metastasis. Furthermore, the diagnosis of NSCLC with <jats:italic>RET<\/jats:italic> fusion was based on liquid-based NGS rather than tissue-based biopsy. The patient showed a good response to selpercatinib, which supports the efficacy of selpercatinib as a treatment for <jats:italic>RET<\/jats:italic>-fusion-positive NSCLC with choroidal metastasis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2023.1178762","type":"journal-article","created":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T04:34:52Z","timestamp":1682397292000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Case Report: A case of ultra-late recurrence of KIF13A-RET fusion non-small cell lung cancer response to selpercatinib"],"prefix":"10.3389","volume":"13","author":[{"given":"Ha-Young","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo-Heon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Geun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Jung","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Sok","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung-Joo","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Chul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taebum","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Duk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Jae","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"6765","DOI":"10.2147\/CMAR.S213553","article-title":"Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection","volume":"11","author":"Sonoda","year":"2019","journal-title":"Cancer Manag Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.1477","article-title":"Ret fusions define a unique molecular and clinicopathologic subtype of non\u2013small-cell lung cancer","volume":"30","author":"Wang","year":"2012","journal-title":"J Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2005653","article-title":"Efficacy of selpercatinib in ret fusion\u2013positive non\u2013Small-Cell lung cancer","volume":"383","author":"Drilon","year":"2020","journal-title":"New Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182574a0b","article-title":"Choroidal metastasis as a presenting manifestation of lung cancer: a report of 3 cases and systematic review of the literature","volume":"91","author":"Singh","year":"2012","journal-title":"Medicine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(02)01580-5","article-title":"Choroidal metastasis in disseminated lung cancer: Frequency and risk factors","volume":"134","author":"Kreusel","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehpc.2020.200421","article-title":"A case of late distant Recurrence\/Metastasis (\u2267 10 years after curative surgery) of anaplastic lymphoma kinase-rearranged lung cancer and the review of similar cases in the literature","volume":"22","author":"Matsuo","year":"2020","journal-title":"Hum Pathology: Case Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103311","article-title":"Next generation sequencing for liquid biopsy based testing in non-small cell lung cancer in 2021","volume":"161","author":"Pisapia","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2017.175","article-title":"Targeting ret-driven cancers: Lessons from evolving preclinical and clinical landscapes","volume":"15","author":"Drilon","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4046\/trd.2022.0066","article-title":"New targeted therapy for non-small cell lung cancer","volume":"86","author":"Chung","year":"2023","journal-title":"Tuberc Respir Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmoldx.2021.12.004","article-title":"Identification and validation of noncanonical RET fusions in non-small-cell lung cancer through DNA and RNA sequencing","volume":"24","author":"Xiang","year":"2022","journal-title":"J Mol Diagn"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-0800","article-title":"Intracranial efficacy of selpercatinib in ret fusion-positive non\u2013small cell lung cancers on the libretto-001 trial","volume":"27","author":"Subbiah","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0656","article-title":"LIBRETTO-432, a phase III study of adjuvant selpercatinib or placebo in stage IB-IIIA RET fusion-positive non-small-cell lung cancer","volume":"18","author":"Tsuboi","year":"2022","journal-title":"Future Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00247-3","article-title":"Pralsetinib for ret fusion-positive non-small-cell lung cancer (Arrow): A multi-cohort, open-label, phase 1\/2 study","volume":"22","author":"Gainor","year":"2021","journal-title":"Lancet Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1178762\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,25]],"date-time":"2023-04-25T04:34:55Z","timestamp":1682397295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2023.1178762\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,25]]},"references-count":13,"alternative-id":["10.3389\/fonc.2023.1178762"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2023.1178762","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,25]]},"article-number":"1178762"}}